Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer
Phase 2
Completed
- Conditions
- Women With Breast Cancer
- Interventions
- Drug: Bisoprolol; Perindopril;
- Registration Number
- NCT04588935
- Lead Sponsor
- State Institution "Republican Scientific and Practical Center" Cardiology, Belarus
- Brief Summary
To develop a method of medical prevention of cardiovascular diseases caused by cardiotoxicity against the background of complex treatment of patients with primary resectable breast cancer to reduce the risk of cardiovascular complications
- Detailed Description
Purpose of the study: to develop a method of medical prevention of cardiovascular diseases caused by cardiotoxicity against the background of complex treatment of patients with primary resectable breast cancer to reduce the risk of cardiovascular complications
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
- women with breast cancer, with a morphologically confirmed diagnosis before the appointment of anticancer therapy.
Exclusion Criteria
- presence of other oncological diseases
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group 2 Bisoprolol; Perindopril; women with breast cancer, with a morphologically confirmed diagnosis before the appointment of anticancer therapy, receiving treatment with a combination of bisoprolol and perindopril
- Primary Outcome Measures
Name Time Method development of cardiovascular diseases and complications 4 years hypertension, cardiomyopathy, arrhythmia's, myocardial infarction, heart failure
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Scientific and Practice Center of Cardiology
🇧🇾Minsk, Belarus